VINCENT FEITOSA: Open Payments
NPI 1437880721 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 5 payments from 2 companies in 2025. Trend: 2023 $110 · 2024 $388 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $283 |
| Otsuka America Pharmaceutical, Inc. | 2 | $276 |
Products named: REXULTI, ARISTADA, LYBALVI.
Industry payments across CA — which companies pay providers there.
